SCM
ATRC icon

Stevens Capital Management’s AtriCure ATRC Stock Holding History

Stevens Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10,655
Closed -$200K – 1049
2014
Q1 		$200K Buy
+10,655
New +$218K 0.01% 926

Other funds holding ATRC

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stevens Capital Management's ATRC Position: Q2 2014 in Review

Stevens Capital Management sold out of AtriCure (ATRC) in Q2 2014, closing a stake of 10,655 shares — an estimated $200K sold.

Stevens Capital Management first reported a position in ATRC in Q1 2014 and held it in 1 quarter. The position peaked at $200K in Q1 2014. 113 funds tracked by Wall St. Rank hold ATRC as of Q2 2014.

  • Stevens Capital Management reported no remaining AtriCure position as of Q2 2014 after selling out during the quarter.
  • Stevens Capital Management sold 10,655 AtriCure shares in Q2 2014, an estimated $200K.
  • Stevens Capital Management first reported a position in AtriCure in Q1 2014 and held it in 1 quarter.
  • Stevens Capital Management's AtriCure position peaked at $200K in Q1 2014.
  • 113 funds tracked by Wall St. Rank held AtriCure as of Q2 2014.

Based on Stevens Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.